Cargando…
NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review
Arylamine N-acetyltransferase 2 has been related to drug side effects and cancer susceptibility; its protein structure and acetylation capacity results from the polymorphism’s arrays on the NAT2 gene. Absorption, distribution, metabolism, and excretion, cornerstones of the pharmacological effects, h...
Autores principales: | Gutiérrez-Virgen, Jorge E., Piña-Pozas, Maricela, Hernández-Tobías, Esther A., Taja-Chayeb, Lucia, López-González, Ma. de Lourdes, Meraz-Ríos, Marco A., Gómez, Rocío |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079069/ https://www.ncbi.nlm.nih.gov/pubmed/37023111 http://dx.doi.org/10.1371/journal.pone.0283726 |
Ejemplares similares
-
Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N‐Acetyltransferase NAT2
por: Conway, Louis P., et al.
Publicado: (2020) -
Protein N-terminal acetylation: NAT 2007–2008 Symposia
por: Arnesen, Thomas
Publicado: (2009) -
Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history
por: Sabbagh, Audrey, et al.
Publicado: (2008) -
Molecular Basis for Amino-Terminal Acetylation by the Heterodimeric NatA Complex
por: Liszczak, Glen, et al.
Publicado: (2013) -
Divergent architecture of the heterotrimeric NatC complex explains N-terminal acetylation of cognate substrates
por: Grunwald, Stephan, et al.
Publicado: (2020)